Diane Carman's most recent trade in Windtree Therapeutics Inc was a trade of 99 Common Stock done . Disclosure was reported to the exchange on Feb. 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Windtree Therapeutics Inc | Diane Carman | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 28 Feb 2023 | 99 | 1,227 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | Diane Carman | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 99,600 | 99,600 | - | - | Employee Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | Diane Carman | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 66,300 | 66,300 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | Diane Carman | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |